ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis
NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to ARDT. ARDT was compared to 103 industry peers in the Health Care Providers & Services industry. ARDT has an average financial health and profitability rating. ARDT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year ARDT was profitable.
In the past year ARDT had a positive cash flow from operations.
1.2 Ratios
With a decent Return On Assets value of 4.57%, ARDT is doing good in the industry, outperforming 77.67% of the companies in the same industry.
Looking at the Return On Equity, with a value of 19.12%, ARDT belongs to the top of the industry, outperforming 86.41% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.15%, ARDT is in the better half of the industry, outperforming 75.73% of the companies in the same industry.
ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.55%.
The last Return On Invested Capital (8.15%) for ARDT is above the 3 year average (5.96%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 19.12% | ||
| ROIC | 8.15% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
ARDT's Profit Margin of 3.73% is fine compared to the rest of the industry. ARDT outperforms 71.84% of its industry peers.
In the last couple of years the Profit Margin of ARDT has grown nicely.
ARDT has a better Operating Margin (6.59%) than 68.93% of its industry peers.
ARDT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 57.32%, ARDT is in the better half of the industry, outperforming 78.64% of the companies in the same industry.
ARDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | 3.73% | ||
| GM | 57.32% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARDT is destroying value.
ARDT has more shares outstanding than it did 1 year ago.
ARDT has a better debt/assets ratio than last year.
2.2 Solvency
ARDT has an Altman-Z score of 2.07. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
ARDT's Altman-Z score of 2.07 is in line compared to the rest of the industry. ARDT outperforms 50.49% of its industry peers.
ARDT has a debt to FCF ratio of 9.36. This is a negative value and a sign of low solvency as ARDT would need 9.36 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.36, ARDT perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
A Debt/Equity ratio of 0.93 indicates that ARDT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.93, ARDT is not doing good in the industry: 63.11% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 9.36 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.98
WACC8.36%
2.3 Liquidity
A Current Ratio of 2.12 indicates that ARDT has no problem at all paying its short term obligations.
ARDT has a better Current ratio (2.12) than 74.76% of its industry peers.
A Quick Ratio of 1.98 indicates that ARDT should not have too much problems paying its short term obligations.
ARDT's Quick ratio of 1.98 is fine compared to the rest of the industry. ARDT outperforms 74.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.98 |
3. Growth
3.1 Past
ARDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 314.38%, which is quite impressive.
Measured over the past years, ARDT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.75% on average per year.
The Revenue has grown by 10.29% in the past year. This is quite good.
The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%53.26%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%4.04%
3.2 Future
ARDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
The Revenue is expected to grow by 6.52% on average over the next years.
EPS Next Y58.8%
EPS Next 2Y29.01%
EPS Next 3Y23.19%
EPS Next 5YN/A
Revenue Next Year8.36%
Revenue Next 2Y6.74%
Revenue Next 3Y6.52%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ARDT is valuated cheaply with a Price/Earnings ratio of 6.40.
96.12% of the companies in the same industry are more expensive than ARDT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.24, ARDT is valued rather cheaply.
The Price/Forward Earnings ratio is 5.04, which indicates a rather cheap valuation of ARDT.
Based on the Price/Forward Earnings ratio, ARDT is valued cheaper than 97.09% of the companies in the same industry.
ARDT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.4 | ||
| Fwd PE | 5.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaply inside the industry as 94.17% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ARDT is valued a bit cheaper than the industry average as 77.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.46 | ||
| EV/EBITDA | 3.84 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ARDT may justify a higher PE ratio.
ARDT's earnings are expected to grow with 23.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y29.01%
EPS Next 3Y23.19%
5. Dividend
5.1 Amount
ARDT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.31
+0.09 (+0.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.26%
Inst Owner Change0.11%
Ins Owners1.98%
Ins Owner Change1.21%
Market Cap1.47B
Analysts82.35
Price Target20.87 (102.42%)
Short Float %1.75%
Short Ratio5.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)59.62%
Min EPS beat(2)43.05%
Max EPS beat(2)76.2%
EPS beat(4)3
Avg EPS beat(4)21.25%
Min EPS beat(4)-44.28%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.04%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)6.1%
Revenue beat(4)1
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.04%
PT rev (3m)1.73%
EPS NQ rev (1m)-36.29%
EPS NQ rev (3m)-44.18%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)1.16%
Revenue NQ rev (1m)-3.25%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.4 | ||
| Fwd PE | 5.04 | ||
| P/S | 0.24 | ||
| P/FCF | 12.46 | ||
| P/OCF | 4.84 | ||
| P/B | 1.25 | ||
| P/tB | 6.65 | ||
| EV/EBITDA | 3.84 |
EPS(TTM)1.61
EY15.62%
EPS(NY)2.05
Fwd EY19.85%
FCF(TTM)0.83
FCFY8.03%
OCF(TTM)2.13
OCFY20.68%
SpS42.12
BVpS8.22
TBVpS1.55
PEG (NY)0.11
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 19.12% | ||
| ROCE | 9.73% | ||
| ROIC | 8.15% | ||
| ROICexc | 9.28% | ||
| ROICexgc | 12.64% | ||
| OM | 6.59% | ||
| PM (TTM) | 3.73% | ||
| GM | 57.32% | ||
| FCFM | 1.96% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 9.36 | ||
| Debt/EBITDA | 2 | ||
| Cap/Depr | 126.81% | ||
| Cap/Sales | 3.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.04% | ||
| Profit Quality | 52.68% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.98 | ||
| Altman-Z | 2.07 |
F-Score8
WACC8.36%
ROIC/WACC0.98
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%53.26%
EPS Next Y58.8%
EPS Next 2Y29.01%
EPS Next 3Y23.19%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%4.04%
Revenue Next Year8.36%
Revenue Next 2Y6.74%
Revenue Next 3Y6.52%
Revenue Next 5YN/A
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year71.17%
EBIT Next 3Y25.43%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A